Massage Therapy May Have Immediate Positive Effect on Pain and Mood for Advanced Cancer Patients
Posted on: Tuesday, 23 September 2008, 21:00 CDT
A new study found that massage therapy may have immediate benefits on pain and mood among patients with advanced cancer. The study, sponsored by the Institute of Medicine and the National Institutes of Health, was a randomized trial of 380 advanced cancer patients at 15 U.S. hospices. In the study, patients had improvement in pain and mood immediately following treatment that was greater with massage than with simple touch.
Pain and depressed mood are common problems for patients with advanced cancer. While drug therapies can reduce symptoms, they don't always work and often have troublesome side effects. Researchers think that massage may interrupt the cycle of distress, offering physical and psychological benefits. Physically, massage may decrease inflammation and edema, increase blood and lymphatic circulation, and relax muscle spasms. Psychologically, massage may promote relaxation, release endorphins, and create a positive experience that distracts temporarily from pain and depression.
Researchers caution that while message may offer some immediate relief for patients with advanced cancer, the effects do not last over time, demonstrating the need for more effective strategies to manage pain at the end of life.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=841170
Media Contact: Steve Majewski ACP Email Contact 215-351-2514
SOURCE: American College of Physicians
Source: MARKET WIRE
Related Articles
- Radiation Therapy Technique Successfully Treats Pain In Patients With Advanced Cancer
- Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer
- Palliative Care Intervention For Patients With Advanced Cancer
- EpiCept Initiates Advanced Cancer Study
- Cephalon Receives FDA Approval of FENTORA(TM) (Fentanyl Buccal Tablet) for the Management of Breakthrough Pain in Patients With Cancer
- Cephalon Receives Approvable Letter for FENTORA(TM) (Fentanyl Buccal Tablet) for Management of Breakthrough Pain in Patients With Cancer
- Study Links Pain Relievers and Breast Cancer
- Regeneron's VEGF Trap Demonstrates Positive Preliminary Results From Single-Agent Phase 1 Trial in Patients With Advanced Cancer; Results Presented at ASCO Annual Meeting on May 16, 2005
- Pro-Pharmaceuticals' ASCO Data Show DAVANAT/5-FU Well-Tolerated in Patients With Advanced Cancer
User Comments (0)


RSS Feeds